Tag: Alzheimer's Disease

Key Takeaways: - Biogen is discontinuing Aduhelm, the controversial Alzheimer's medicine. - Aduhelm's rights will revert to Neurimmune, the discovering Swiss biopharmaceutical company. - The Phase 4...

A new drug therapy may change the way millions of people visit the dentist. An Alzheimer's drug was able to fill cavities without the need...

Researchers that focus on Alzheimer’s Disease have recently taken interest in brain insulin resistance. In April 2016, researchers at the Mount Sinai Health System...